by Stacey Hawkins | Jul 21, 2016 | Infectious Disease
THE STATE OF ANTIBACTERIALS One of the greatest public health challenges of the 21st century is antibiotic resistance, which occurs when a few bacteria in a given population develop a genetic mutation that enables them to survive—even in the presence of antibiotics.... by Stacey Hawkins | Jun 17, 2015 | Uncategorized
THE STATE OF ANTIBIOTICS One of the greatest public health challenges of the twenty first century—drug resistant bacteria—prompted the first ever Antibiotics Summit at the White House earlier this month. Antibiotic resistance occurs when a few bacteria in a given... by Stacey Hawkins | May 29, 2014 | Uncategorized
MRSA’S MATCH Last week, the FDA approved Dalvance, Chicago-based Durata Therapeutic’s new antibacterial drug for the treatment of methicillin-resistant staphylococcus aureus (MRSA) infections. Why is Dalvance newsworthy? MRSA is an infectionthatis difficult to...
